Skip to main content
logo
ZyVersa Therapeutics, Inc. (ZVSA)
OTCMKTS · Delayed Price · Currency is USD
0.1134
+0.0144 (14.55%)
At close: Sep 18, 2026

ZyVersa Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Quarter
Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q4 2020
Period Ending
Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Dec '20
Net Income
-24.49-24.95-25.7-8.29-8.84-9.41-21.33-21.83-97.58-98.3-89.64-90.43-13.92-14.12-11.41-9.6-9.69-8.08-12.68
Depreciation & Amortization
---000.01-0.110.010.010.010.130.010.010.010.010.010.010.010.01
Other Amortization
0.060.06---------00.010.040.110.190.270.320.29
Asset Writedown & Restructuring Costs
18.6518.6518.65---12.1612.1693.3393.3381.1881.18-------
Stock-Based Compensation
0.120.220.370.450.640.710.840.921.131.191.351.61.933.583.954.865.194.143.68
Other Operating Activities
-0.26-0.61-0.50.330.120.21-0.29-0.39-6.84-7.56-7.64-7.36-0.92-0.050.41-0.24-0.22-0.440.49
Change in Accounts Payable
0.610.690.450.921.380.890.210.171.752.413.964.453.664.543.822.561.28-0.31-0.6
Change in Other Net Operating Assets
1.160.830.781.431.180.08-0.57-0.460.30.190.931.360.121.121.420.22-0.02-0.713.71
Operating Cash Flow
-4.14-5.11-5.96-5.16-5.51-7.52-9.09-9.41-7.91-8.72-9.74-9.2-9.1-4.89-1.69-2-3.19-5.08-5.11
Operating Cash Flow Growth (YoY)
-------------------

Financing Activities

Fiscal Quarter
Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q4 2020
Period Ending
Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Dec '20
Long-Term Debt Issued
-----------------5.231.69
Total Debt Issued
1----------------5.231.69
Net Debt Issued (Repaid)
1----------------5.231.69
Issuance of Common Stock
2.052.055.093.873.876.548.510.7421.7519.0814.0811.02------3.02
Repurchase of Common Stock
---------0.01-0.01-0.01-0.01-------
Other Financing Activities
-0.221.631.271.251.22-0.63-0.86-1.2-2.39-2.42-1.81-1.59-0.11-0.1-0.060.27-0.03--0.14
Financing Cash Flow
2.833.696.365.125.095.917.649.318.665.962.120.51.441.871.350.690.395.234.56

Net Cash Flow

Fiscal Quarter
Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q4 2020
Period Ending
Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Dec '20
Miscellaneous Cash Flow Adjustments
--------0---0-------
Net Cash Flow
-1.31-1.430.41-0.05-0.42-1.61-1.46-0.110.76-2.76-7.62-8.7-7.67-3.02-0.34-1.31-2.80.15-0.55

Free Cash Flow

Fiscal Quarter
Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q4 2020
Period Ending
Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Dec '20
Levered Free Cash Flow
-2.18-2.88-3.67-1.97-2.1-4.09-5.34-5.54-4.99-5.46-7.05-6.63-6.02-1.65----2.02-
Unlevered Free Cash Flow
-1.85-2.56-3.35-1.65-1.86-3.92-5.25-5.54-4.99-5.46-7.02-6.56-5.87-1.43----1.83-

Additional Metrics

Fiscal Quarter
Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q4 2020
Period Ending
Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Dec '20
Change in Working Capital
1.771.521.222.352.560.97-0.36-0.292.042.64.895.813.795.665.242.781.25-1.023.11